Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Inger Sandlie0
Agnete Brunsvik Fredriksen0
Bjarne Bogen0
Date of Patent
October 24, 2017
0Patent Application Number
148722900
Date Filed
October 1, 2015
0Patent Primary Examiner
Patent abstract
Recombinant antibody-based molecules that trigger both T-cell and B-cell immune responses are disclosed. The recombinant molecules are comprised by at least one targeting unit and at least one antigenic unit connected through a dimerization motif. Also disclosed are nucleic acid molecules encoding the recombinant antibody-based molecule and methods of treating multiple myeloma or lymphoma in a patient using the recombinant antibody-based molecules or the nucleic acid molecules.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.